On Sunday, Arcellx, Inc. (NASDAQ:ACLX) revealed new data from its Phase 2 pivotal iMMagine-1 study of anitocabtagene autoleucel (anito-cel) in patients with relapsed or refractory multiple myeloma ...
Arcellx shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82.
Arcellx stock reversed lower Monday on positive results for its rival to Legend Biotech's multiple myeloma treatment, Carvykti. A gut-health scientist and chef eats fermented foods every day.
Cell therapy developer Arcellx contends its lead program could be a safer alternative to currently available CAR T-treatments for multiple myeloma, noting that its previously reported preliminary ...
I just returned from San Diego and the annual meeting of the American Society of Hematology, where Arcellx won the battle of BCMA CAR-T therapies against Legend Biotech. Legend has downplayed the ...
Arcellx shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82.
Arcellx's Cancer Cell Therapy Shows Deep, Durable Responses With Manageable Safety Profile In Heavily Pretreated Blood Cancer Patients On Sunday, Arcellx, Inc. (NASDAQ:ACLX) revealed new data from ...
Oppenheimer laid out five “aspirational” potential takeover targets in biotech heading into the annual JPMorgan Health Care Conference. “We ...
H.C. Wainwright analyst Emily Bodnar has maintained their bullish stance on ACLX stock, giving a Buy rating today.Pick the best stocks and ...
Arcellx, Inc. (NASDAQ:ACLX – Free Report) – Leerink Partnrs issued their Q1 2025 earnings estimates for shares of Arcellx in a research report issued to clients and investors on Wednesday ...
Arcellx, Inc. (NASDAQ:ACLX), a U.S. biopharmaceutical company valued at $4.57 billion, has been making waves in the cell therapy space with its innovative approach to treating multiple myeloma and ...
Arcellx stock reversed lower Monday despite positive results for its rival to Legend Biotech's multiple myeloma treatment, Carvykti. Please watch the video at Investors.com - How To Buy Stocks ...